Demodex folliculorum, a tiny microscopic bug may
be harmless to most people, but is a huge concern for those affected by
rosacea. This tiny spider-like bug crawls over the face, emerging from the
pores of your skin while you are asleep, and once it dies, it releases bacteria
which trigger inflammation of tissues, particularly in patients suffering from
This inflammation can, in fact, worsen the condition
and result in a severe form of rosacea known as papulopustular rosacea.
Thankfully, researchers have now developed what we like to call the
breakthrough treatment, which could help those suffering from rosacea tackle
this condition that often ends up giving them a red, swollen face with
A new insecticide
has been developed to
tackle these mites, and not surprisingly, it is actually derived from compounds
that are used to deal with mite infestations and scabies
in animals. This insecticide contains a compound known as ivermectin
, which is safe and
effective, and is thought to cure almost half of the patients suffering from
rosacea who didn't respond to other treatment options.
"This is genuinely a breakthrough treatment for
the severest type of rosacea and it is showing remarkable success in easing
this distressing skin
," dermatologist Dr Nick Lowe, of London's Cranley Clinic,
explained. It is speculated that rosacea sufferers have around 10 times more
'mites' on their face, and this new insecticide-cum-cream works by killing
these mites. What's more, this insecticide also deals with skin spots and
reduces facial redness dramatically.
The researchers asked the study subjects
suffering from moderate-to-severe rosacea to apply the insecticide cream once
at night for a period of 12 weeks. Follow ups revealed that around 40% of the
patients reported their skin was almost clear, and overall, around 70% patients
rated their skin quality as excellent or good.
"I didn't expect to see such dramatic
improvement so rapidly and so consistently, in treated patients," says Dr Linda
Stein Gold, a US dermatologist and lead investigator in the Ivermectin study.
The researchers have now submitted an application to the health authorities in
the UK, which will probably help dermatologists to start using this new cream
legally from 2015.
It is estimated that around 1 in every 10 people
in the UK suffer from rosacea- a genetic skin condition that usually turns up
after 30 years of age. This painful skin condition causes the blood vessels on
the face to dilate, which may lead to painful
and redness of the skin, acne
pus-filled spots, uncontrollable flushing and possible eye
too. The current treatments for rosacea include oral antibiotics
topical creams and others.